ELC and Lauder Family Further Commitment to Eliminating Breast Cancer Disparities

To reinforce and build upon The Estée Lauder Companies’ (ELC) legacy of breast cancer funding and furthering the company’s commitment to Racial Equity, the company and the Lauder Family will invest $1 million over two years towards research to help eliminate breast cancer disparities. Through grants with the Breast Cancer Research Foundation (BCRF), two important new initiatives will be supported.

The first grant will support Dr. Nikhil Wagle of Dana-Farber Cancer Institute and will aim to both improve our understanding of metastatic breast cancer in Black patients and expand the participation of Black breast cancer patients in clinical research. By studying the progression of disease and response to therapies specifically in Black patients, Dr. Wagle’s work is expected to help lead to targeted therapies, precision medicine and improved outcomes specifically for Black patients.

Through work in partnership with the American Society of Clinical Oncology and the American Association of Cancer Research, the second grant will support a new directive through BCRF to provide funding to early-career, under-represented investigators in the breast cancer research field, or research aimed at breast cancer disparities. This work is expected to have a significant impact on the career development for early-stage investigators at a critical juncture in their career path.

It’s #TimeToEndBreastCancer.

Christine Schott Ledes
Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *